enVVeno Medical Corp SEC filings NVNO
enVVeno Medical Corp has 415 filings in SEC EDGAR's recent list, going back to Dec 15, 2015. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Feb 28, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 2, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | May 11, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 18, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 14, 2019 | Dec 31, 2018 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NVNO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1661053
- Former names
- Hancock Jaffe Laboratories, Inc. (until Sep 22, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.